Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
5
×
life sciences
5
×
national blog main
biotech
boston blog main
fda
amgen
cancer
indiana blog main
indiana top stories
national top stories
new york blog main
new york top stories
san diego blog main
san francisco blog main
san francisco top stories
sanofi
seattle blog main
seattle top stories
startups
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
andrew berens
anirvan ghosh
astrazeneca
avapritinib
biogen
blood draw
blood tests
blueprint medicines
bluerock therapeutics
boston
boston top stories
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
What
announced
5
×
drug
medicines
approval
ceo
fda
medicine
plans
week
aces
acquisitions
approved
based
big
bio
blood
blueprint
bodily
cancer
captures
chasing
cholesterol
class
collabs
collecting
contamination
covid
culture
daniel
deadly
deal
deciphera
decision
developed
devices
eli
filing
flexible
fluids
forms
Language
unset
Current search:
announced
×
" life sciences "
×
" clinical trials "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
Magnolia Medical Captures $20M to Reduce Blood Culture Contamination
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines